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Quality of life (QOL) measurements have become an 
end-point that is as important as survival and effectiveness.1 
More and more emphasis is being placed on QOL outcomes 
in urology, as evidenced by the development of minimally 
invasive procedures and the use of diaries and validated 
questionnaires in research and clinical practice.2
Health-related quality of life may incorporate a wide 
variety of subjective concepts, such as general health, 
physical symptoms, role functioning, and social well-
being. Data generated by patient-reported outcome (PRO) 
instruments provide a means for measuring treatment 
benefits that are known only to the patient.3, 4
The literature reveals that the most appropriate judge 
of individual QOL is the patient him- or herself.5 Different 
treatments may be associated with long-term complications 
that could adversely affect QOL.
In urological oncology, regardless of oncological safety, 
patients and their physicians make decisions based on quality 
of life issues, such as: sexual, bowel, and urinary function 
and bother.
Since February 2006, our research group has been 
working in cooperation with Dr. Mark Litwin (University of 
California – Los Angeles) in order to translate and validate 
a Portuguese version of the UCLA Prostate Cancer Index 
(UCLA-PCI).6 This questionnaire is a cross-culturally 
validated instrument that is available in many languages and 
is considered as the gold-standard for evaluation of QOL in 
prostate cancer patients.5 
We have also been working on a project designed to 
develop the Brazilian bladder and prostate questionnaire 
modules with the European Organization for Research and 
Treatment of Cancer (EORTC) QOL Group (Dr. N Aaronson 
and Ms. Linda Dewolf).7 The EORTC PR25 (prostate), 
BLS24 (superficial bladder cancer), and BLM30 (muscle-
invasive bladder cancer) questionnaires have been culturally 
adapted for the Brazilian context.
The  use  of  cancer-specific  modules  has  made 
standardization of results possible, thus minimizing the 
variability of concepts between medical specialties and 
between authors in different countries.4
Indeed, we anticipated several distress factors that can 
contribute to a lower response rate of our patients, including 
the low literacy level of the Brazilian population, the 
presence of words that require minimal technical knowledge, 
and the fact that patients are often unwilling to disclose 
private information, such as sexual matters, on paper, thus 
resulting in missing data.
The aim of this brief communication is to emphasize 
the importance of these questionnaires in our country 
when comparing urinary continence data from patient files 
registered by the attendant physician with the respective 
patient answers using a validated urinary incontinence-
specific measure (International Consultation on Incontinence 
Questionnaire Short Form, ICIQ-SF). The PCI item 
regarding the number of pads or adult diapers was also 
applied.
Thirty medical files among the 210 patients included in 
the Brazilian UCLA-PCI project validation were randomly 
selected and reviewed.
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diagnosed only 40% (12/30) of the cases. Considering 
grades of urinary incontinence, the urologist was accurate 
only 44% (13/30) of the time. The number of pads 
registered differed between the medical file and the patient 
self-report in 20% of the cases (6/30). Even when patients 
were considered as perfectly continent by the physician, 
53% (8/15) of them reported that urinary incontinence 
interfered with their daily life. Even worse, seven patients 
diagnosed as continent by the physicians reported that 
urinary incontinence had a significant negative impact on 
their daily activities.
TAKE-HOME MESSAGE
Patient self-reports differ from health professional 
evaluations.  Health  professional  registries  tend  to 
underestimate the severity of symptoms. The use of validated 
questionnaires is paramount in clinical studies.
The psychometric tests (i.e., reliability, validation) 
comprising of UCLA-PCI and EORTC PR25 have been 
performed, and the results of these tests will soon be 
presented. The EORTC bladder modules are still in Phase 3 
of development. All four of the PRO questionnaires (UCLA-
PCI, EORTC PR25, BLS24, and BLM30) are now available 
for clinical trials in Brazil.
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